1. Home
  2. CERO vs DPRO Comparison

CERO vs DPRO Comparison

Compare CERO & DPRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CERO
  • DPRO
  • Stock Information
  • Founded
  • CERO 2017
  • DPRO 1998
  • Country
  • CERO United States
  • DPRO Canada
  • Employees
  • CERO N/A
  • DPRO N/A
  • Industry
  • CERO
  • DPRO Aerospace
  • Sector
  • CERO
  • DPRO Industrials
  • Exchange
  • CERO Nasdaq
  • DPRO Nasdaq
  • Market Cap
  • CERO 8.5M
  • DPRO 9.3M
  • IPO Year
  • CERO N/A
  • DPRO N/A
  • Fundamental
  • Price
  • CERO $0.06
  • DPRO $4.09
  • Analyst Decision
  • CERO
  • DPRO Strong Buy
  • Analyst Count
  • CERO 0
  • DPRO 2
  • Target Price
  • CERO N/A
  • DPRO $6.00
  • AVG Volume (30 Days)
  • CERO 33.3M
  • DPRO 749.8K
  • Earning Date
  • CERO 11-19-2024
  • DPRO 11-14-2024
  • Dividend Yield
  • CERO N/A
  • DPRO N/A
  • EPS Growth
  • CERO N/A
  • DPRO N/A
  • EPS
  • CERO N/A
  • DPRO N/A
  • Revenue
  • CERO N/A
  • DPRO $4,340,793.00
  • Revenue This Year
  • CERO N/A
  • DPRO $30.90
  • Revenue Next Year
  • CERO N/A
  • DPRO $112.38
  • P/E Ratio
  • CERO N/A
  • DPRO N/A
  • Revenue Growth
  • CERO N/A
  • DPRO N/A
  • 52 Week Low
  • CERO $0.05
  • DPRO $1.55
  • 52 Week High
  • CERO $12.80
  • DPRO $12.55
  • Technical
  • Relative Strength Index (RSI)
  • CERO 39.14
  • DPRO 55.67
  • Support Level
  • CERO $0.05
  • DPRO $3.79
  • Resistance Level
  • CERO $0.21
  • DPRO $5.34
  • Average True Range (ATR)
  • CERO 0.02
  • DPRO 0.87
  • MACD
  • CERO -0.01
  • DPRO 0.04
  • Stochastic Oscillator
  • CERO 14.60
  • DPRO 46.14

About CERO CERo Therapeutics Holdings Inc. Common Stock

CERo Therapeutics Holdings Inc is an innovative immunotherapy company advancing the development of next-generation engineered T-cell therapeutics for the treatment of cancer. Its proprietary approach to T cell engineering, which enables it to integrate certain desirable characteristics of both innate and adaptive immunity into a single therapeutic construct, is designed to engage the body's full immune repertoire to achieve optimized cancer therapy.

About DPRO Draganfly Inc.

Draganfly Inc is a Canada based company. It is engaged in the provision of engineering services and the manufacture of commercial unmanned vehicle systems and software. The company operates in Canada, the United States, and Internationally. The three segments are Drones, Vital (Vital Intelligence), and Corporate. The Drones segment derives its revenue from products and services related to the sale of unmanned aerial vehicles (UAV). The Vital segment derives its revenue from the sale of products that measure vitals to help detect symptoms from large groups of people from a distance. The Corporate segment includes all costs not directly associated with the Drone and Vital segments. It generates majority of its revenue from Drones segment.

Share on Social Networks: